GUD.TO
Knight Therapeutics Inc
Price:  
5.74 
CAD
Volume:  
58,814.00
Canada | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

GUD.TO WACC - Weighted Average Cost of Capital

The WACC of Knight Therapeutics Inc (GUD.TO) is 6.6%.

The Cost of Equity of Knight Therapeutics Inc (GUD.TO) is 6.35%.
The Cost of Debt of Knight Therapeutics Inc (GUD.TO) is 12.00%.

Range Selected
Cost of equity 5.20% - 7.50% 6.35%
Tax rate 22.30% - 26.90% 24.60%
Cost of debt 7.90% - 16.10% 12.00%
WACC 5.3% - 7.9% 6.6%
WACC

GUD.TO WACC calculation

Category Low High
Long-term bond rate 3.3% 3.8%
Equity market risk premium 5.1% 6.1%
Adjusted beta 0.38 0.52
Additional risk adjustments 0.0% 0.5%
Cost of equity 5.20% 7.50%
Tax rate 22.30% 26.90%
Debt/Equity ratio 0.12 0.12
Cost of debt 7.90% 16.10%
After-tax WACC 5.3% 7.9%
Selected WACC 6.6%